Zachary Braunstein

1.6k total citations
36 papers, 1.1k citations indexed

About

Zachary Braunstein is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Zachary Braunstein has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 17 papers in Immunology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Zachary Braunstein's work include Lymphoma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (6 papers) and T-cell and Retrovirus Studies (5 papers). Zachary Braunstein is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (6 papers) and T-cell and Retrovirus Studies (5 papers). Zachary Braunstein collaborates with scholars based in United States, China and Canada. Zachary Braunstein's co-authors include Jixin Zhong, Xiaoquan Rao, Chang Xia, Sanjay Rajagopalan, Yuan Yang, Boxu Ren, Lian Liu, Dean J. Mikami, Bradley Needleman and Abhay R. Satoskar and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Zachary Braunstein

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zachary Braunstein United States 12 376 288 174 174 138 36 1.1k
Chang Xia United States 14 323 0.9× 341 1.2× 106 0.6× 118 0.7× 119 0.9× 20 931
Eugeniusz J. Kucharz Poland 20 283 0.8× 292 1.0× 90 0.5× 139 0.8× 117 0.8× 186 1.4k
Tonya Watkins United States 22 814 2.2× 319 1.1× 131 0.8× 130 0.7× 76 0.6× 37 1.5k
Barbara Toffoli Italy 21 560 1.5× 263 0.9× 174 1.0× 153 0.9× 220 1.6× 45 1.2k
Carlos Encinas Dominguez United States 6 345 0.9× 151 0.5× 161 0.9× 114 0.7× 239 1.7× 6 1.8k
Sung Woo Park South Korea 19 489 1.3× 278 1.0× 108 0.6× 161 0.9× 64 0.5× 54 1.2k
Anna Severino Italy 23 679 1.8× 270 0.9× 128 0.7× 275 1.6× 46 0.3× 58 1.5k
Taro Horino Japan 20 581 1.5× 174 0.6× 73 0.4× 233 1.3× 125 0.9× 117 1.5k
Hui Ding China 21 552 1.5× 170 0.6× 150 0.9× 170 1.0× 128 0.9× 67 1.5k

Countries citing papers authored by Zachary Braunstein

Since Specialization
Citations

This map shows the geographic impact of Zachary Braunstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachary Braunstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachary Braunstein more than expected).

Fields of papers citing papers by Zachary Braunstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachary Braunstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachary Braunstein. The network helps show where Zachary Braunstein may publish in the future.

Co-authorship network of co-authors of Zachary Braunstein

This figure shows the co-authorship network connecting the top 25 collaborators of Zachary Braunstein. A scholar is included among the top collaborators of Zachary Braunstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachary Braunstein. Zachary Braunstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brammer, Jonathan E., Zachary Braunstein, Patrick Stevens, et al.. (2025). Targeting the methylome in T-LGL leukemia: Pre-clinical analysis and Results of a Phase I trial with oral 5-azacytidine. Blood. 146(Supplement 1). 890–890.
2.
Zhou, Mi, Zhiwen Huang, Jun Chen, et al.. (2025). The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy. Cancer Drug Resistance. 8. 34–34. 2 indexed citations
3.
Wei, Yingying, Jie Huang, Zachary Braunstein, et al.. (2024). Midline-1 regulates effector T cell motility in experimental autoimmune encephalomyelitis via mTOR/microtubule pathway. Theranostics. 14(3). 1168–1180. 4 indexed citations
4.
Braunstein, Zachary, et al.. (2024). Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia. Haematologica. 110(4). 995–998. 1 indexed citations
6.
Moustafa, Muhamad Alhaj, Jeremy Ramdial, Athanasios Tsalatsanis, et al.. (2024). A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma. Transplantation and Cellular Therapy. 30(5). 516.e1–516.e10.
7.
Li, Wenjuan, Zhiwen Huang, Jeffrey A. Deiuliis, et al.. (2024). Deciphering the therapeutic potential of Myeloid-Specific JAK2 inhibition in acute respiratory distress syndrome. Mucosal Immunology. 17(6). 1273–1284. 1 indexed citations
8.
Huang, Zhiwen, Zachary Braunstein, Jun Chen, et al.. (2024). Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates. Pharmacological Reviews. 76(4). 579–598. 9 indexed citations
9.
Braunstein, Zachary, Eric McLaughlin, Walter Hanel, et al.. (2023). Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas. Leukemia & lymphoma. 65(3). 301–311. 1 indexed citations
10.
Rao, Xiaoquan, Georgeta Mihai, Yingying Wei, et al.. (2023). Dipeptidyl Peptidase 4/Midline‐1 Axis Promotes T Lymphocyte Motility in Atherosclerosis. Advanced Science. 10(9). e2204194–e2204194. 9 indexed citations
11.
Wei, Yingying, Zachary Braunstein, Jun Chen, et al.. (2023). JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization. International Immunopharmacology. 120. 110382–110382. 7 indexed citations
12.
Braunstein, Zachary, et al.. (2023). Sex differences in particulate air pollution-related cardiovascular diseases: A review of human and animal evidence. The Science of The Total Environment. 884. 163803–163803. 51 indexed citations
13.
Braunstein, Zachary, Eric McLaughlin, Anjali Mishra, & Jonathan E. Brammer. (2022). Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia. Blood Advances. 6(8). 2685–2687. 6 indexed citations
14.
Malik, Saad Ullah, Zachary Braunstein, Sumithira Vasu, et al.. (2021). Cardiac Arrhythmias and Mortality after Hematopoietic Stem Cell Transplant (HSCT): A Systematic Review and Meta-Analysis. Blood. 138(Supplement 1). 2918–2918. 1 indexed citations
15.
Zhong, Jixin, Guifen Shen, Huiqin Yang, et al.. (2020). COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. The Lancet Rheumatology. 2(9). e557–e564. 79 indexed citations
16.
Braunstein, Zachary, et al.. (2020). Clinical outcomes in T‐cell large granular lymphocytic leukaemia: prognostic factors and treatment response. British Journal of Haematology. 192(3). 484–493. 10 indexed citations
17.
Rao, Xiaoquan, Zachary Braunstein, Hong Mao, et al.. (2019). Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways. EBioMedicine. 41. 50–61. 33 indexed citations
18.
Xia, Chang, Xiaoquan Rao, Zachary Braunstein, et al.. (2019). MRP14 enhances the ability of macrophage to recruit T cells and promotes obesity-induced insulin resistance. International Journal of Obesity. 43(12). 2434–2447. 8 indexed citations
19.
Xia, Chang, et al.. (2018). S100 Proteins As an Important Regulator of Macrophage Inflammation. Frontiers in Immunology. 8. 1908–1908. 295 indexed citations
20.
Duan, Lihua, et al.. (2017). Role of Incretin Axis in Inflammatory Bowel Disease. Frontiers in Immunology. 8. 1734–1734. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026